{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:48:05Z","timestamp":1789170485128,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.medj.2025.100608","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:53:54Z","timestamp":1741085634000},"page":"100608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Results from the phase 2\/3 DAFFODIL study of trofinetide in girls aged 2\u20134 years with Rett syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"Alan K.","family":"Percy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ryther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Neul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Benke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Feyma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitha L.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Buhrfiend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilesh","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathie M.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Youakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100608_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13643-023-02169-6","article-title":"Global prevalence of Rett syndrome: systematic review and meta-analysis","volume":"12","author":"Petriti","year":"2023","journal-title":"Syst. Rev."},{"key":"10.1016\/j.medj.2025.100608_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.medj.2025.100608_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.medj.2025.100608_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fncel.2014.00018","article-title":"Developmental and maintenance defects in Rett syndrome neurons identified by a new mouse staging system in vitro","volume":"8","author":"Baj","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.medj.2025.100608_bib5","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/cercor\/bhv078","article-title":"Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms","volume":"26","author":"Bedogni","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.medj.2025.100608_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cne.22009","article-title":"Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks","volume":"514","author":"Belichenko","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ana.22124","article-title":"Rett syndrome: revised diagnostic criteria and nomenclature","volume":"68","author":"Neul","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MPG.0b013e31824b6159","article-title":"Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome","volume":"55","author":"Motil","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.medj.2025.100608_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1866-1955-6-20","article-title":"Developmental delay in Rett syndrome: data from the natural history study","volume":"6","author":"Neul","year":"2014","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.medj.2025.100608_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mrdd.10020","article-title":"Clinical manifestations and stages of Rett syndrome","volume":"8","author":"Hagberg","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.medj.2025.100608_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.22154","article-title":"Rett syndrome diagnostic criteria: lessons from the Natural History Study","volume":"68","author":"Percy","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100608_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2023.11.005","article-title":"Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome","volume":"152","author":"Neul","year":"2024","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.medj.2024.05.018","article-title":"Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study","volume":"5","author":"Percy","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.medj.2025.100608_bib15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.medj.2024.06.007","article-title":"Trofinetide for the treatment of Rett syndrome: long-term safety and efficacy results of the 32-month, open-label LILAC-2 study","volume":"5","author":"Percy","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.medj.2025.100608_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pediatrneurol.2015.02.007","article-title":"Age of diagnosis in Rett syndrome: patterns of recognition among diagnosticians and risk factors for late diagnosis","volume":"52","author":"Tarquinio","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/345270","article-title":"Rett syndrome: coming to terms with treatment","volume":"2014","author":"Percy","year":"2014","journal-title":"Adv. Neurosci."},{"key":"10.1016\/j.medj.2025.100608_bib18","article-title":"Weight-Based Banded Dosing to Achieve Target Exposure and Exposure-Response Safety Analyses to Support Trofinetide Treatment in Girls With Rett Syndrome Aged 2\u20134 Years [eposter]","author":"Darwish","year":"2023","journal-title":"Am. Soc. Clin. Pharmacol. The"},{"key":"10.1016\/j.medj.2025.100608_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s12325-024-03058-7","article-title":"Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2\u20134 Years with Rett Syndrome","volume":"42","author":"Darwish","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.medj.2025.100608_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11689-023-09502-z","article-title":"Top Caregiver Concerns in Rett syndrome and related disorders: data from the US Natural History Study","volume":"15","author":"Neul","year":"2023","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.medj.2025.100608_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/17518423.2013.879940","article-title":"Parental perspectives on the communication abilities of their daughters with Rett syndrome","volume":"19","author":"Urbanowicz","year":"2016","journal-title":"Dev. Neurorehabilit."},{"key":"10.1016\/j.medj.2025.100608_bib22","unstructured":"International Rett Syndrome Foundation and Rett Syndrome Research Trust. Voice of the patient report: Rett syndrome externally-led patient focused drug development meeting [March 11, 2022]. (2022). https:\/\/rettpfdd.org\/site\/assets\/files\/1\/2022-rett-syndrome-voice-of-the-patient-report.pdf."},{"key":"10.1016\/j.medj.2025.100608_bib23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1177\/0883073815579707","article-title":"Improving treatment trial outcomes for Rett syndrome: the development of Rett-specific anchors for the Clinical Global Impression Scale","volume":"30","author":"Neul","year":"2015","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.medj.2025.100608_bib24","doi-asserted-by":"crossref","first-page":"e1912","DOI":"10.1212\/WNL.0000000000007316","article-title":"Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome","volume":"92","author":"Glaze","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100608_bib25","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"218","article-title":"Clinical global impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.medj.2025.100608_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1469-8749.2003.tb00923.x","article-title":"Assessing the impact of pediatric epilepsy and concomitant behavioral, cognitive, and physical\/neurologic disability: Impact of Childhood Neurologic Disability Scale","volume":"45","author":"Camfield","year":"2003","journal-title":"Dev. Med. Child Neurol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:00:39Z","timestamp":1762639239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666634025000352"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100608","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Results from the phase 2\/3 DAFFODIL study of trofinetide in girls aged 2\u20134 years with Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100608"}}